Literature DB >> 17653603

Survival of Huntington's disease patients in Serbia: longer survival in female patients.

Tatjana Pekmezovic1, Marina Svetel, Jelena Maric, Irena Dujmovic-Basuroski, Natasa Dragasevic, Milica Keckarevic, Stanka Romac, Vladimir S Kostic.   

Abstract

The objective of this study was to estimate probability of survival of Huntington's disease (HD) patients in Serbia as a function of CAG repeat length and selected demographic variables. This follow-up study was carried out at the Institute of Neurology, Clinical Centre of Serbia, Belgrade, 1982-2004. The study group consisted of 112 HD patients. The significant inverse correlation was found between CAG repeat length and age at onset of HD (r = -0.732, P = 0.001) and age at death (r = -0.760, P = 0.001). The cumulative probabilities of survival in a five, ten, fifteen, and twenty-years' period were 90.9, 63.2, 10.3 and 4.5%, respectively. Higher survival probabilities were registered in female patients, as well as in those with older age at onset and lower number of CAG repeat length (</=46). The Cox regression analysis showed that significantly poorer outcome of HD in our population was related to younger age at onset (HR-hazard ratio = 1.9; P = 0.047), and larger CAG numbers (HR = 2.4; P = 0.071). The female sex was statistically significantly associated with longer survival (HR = 0.4; P = 0.007). These data might be of some importance for further exploration of natural history and prognosis of HD.

Entities:  

Mesh:

Year:  2007        PMID: 17653603     DOI: 10.1007/s10654-007-9157-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  18 in total

Review 1.  Is there a connection between estrogen and Parkinson's disease?

Authors:  Lisa M Shulman
Journal:  Parkinsonism Relat Disord       Date:  2002-06       Impact factor: 4.891

2.  Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease.

Authors:  B Culjkovic; O Stojkovic; N Vojvodic; M Svetel; L Rakic; S Romac; V Kostic
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

3.  Differences in duration of Huntington's disease based on age at onset.

Authors:  T Foroud; J Gray; J Ivashina; P M Conneally
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Trinucleotide repeat length and rate of progression of Huntington's disease.

Authors:  S N Illarioshkin; S Igarashi; O Onodera; E D Markova; N N Nikolskaya; H Tanaka; T Z Chabrashwili; N G Insarova; K Endo; I A Ivanova-Smolenskaya
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422

6.  Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.

Authors:  P Kehoe; M Krawczak; P S Harper; M J Owen; A L Jones
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

7.  Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia.

Authors:  Manolis Markianos; Marios Panas; Nikos Kalfakis; Dimitrios Vassilopoulos
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

8.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.

Authors:  R G Snell; J C MacMillan; J P Cheadle; I Fenton; L P Lazarou; P Davies; M E MacDonald; J F Gusella; P S Harper; D J Shaw
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

9.  Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.

Authors:  S Furtado; O Suchowersky; B Rewcastle; L Graham; M L Klimek; A Garber
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

10.  Huntington's disease: clinical correlates of disability and progression.

Authors:  N Mahant; E A McCusker; K Byth; S Graham
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

View more
  8 in total

1.  Substance abuse may be a risk factor for earlier onset of Huntington disease.

Authors:  Joanne A Byars; Leigh J Beglinger; David J Moser; Pedro Gonzalez-Alegre; Peg Nopoulos
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

2.  The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.

Authors:  A Reiner; D C Lafferty; H B Wang; N Del Mar; Y P Deng
Journal:  Neurobiol Dis       Date:  2012-03-27       Impact factor: 5.996

Review 3.  Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders.

Authors:  Nimra Hasnain; Taha Bin Arif; Roha Shafaut; Faiza Zakaria; Syeda Zainab Fatima; Ibtehaj Ul Haque
Journal:  Wien Med Wochenschr       Date:  2022-06-20

4.  Deletion of the huntingtin proline-rich region does not significantly affect normal huntingtin function in mice.

Authors:  Michelle Neveklovska; Erin B D Clabough; Joan S Steffan; Scott O Zeitlin
Journal:  J Huntingtons Dis       Date:  2012

5.  Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.

Authors:  Dika A Kuljis; Laura Gad; Dawn H Loh; Zoë MacDowell Kaswan; Olivia N Hitchcock; Cristina A Ghiani; Christopher S Colwell
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

6.  Age at Death and Causes of Death in Patients with Huntington Disease in Norway in 1986-2015.

Authors:  Olga Karin Solberg; Petra Filkuková; Jan C Frich; Kristin J Billaud Feragen
Journal:  J Huntingtons Dis       Date:  2018

7.  The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease.

Authors:  Jae Whan Keum; Aram Shin; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Kawther Abu Elneel; Diane Lucente; Tiffany Hadzi; Peter Holmans; Lesley Jones; Michael Orth; Seung Kwak; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  Am J Hum Genet       Date:  2016-02-04       Impact factor: 11.025

8.  Survival of Korean Huntington's Disease Patients.

Authors:  Han-Joon Kim; Chae-Won Shin; Beomseok Jeon; Hyeyoung Park
Journal:  J Mov Disord       Date:  2016-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.